Skip to main content
. 2017 Jun 22;6(7):1817–1826. doi: 10.1002/cam4.1122

Table 2.

Five‐year overall survival of patients in each ICCC category with common subtypes having cases more than the predetermined cutoff and according to sex, race, era of diagnosis, geographic region and treatment received

Broad Grouping ICCC Gender (95% CI) Race (95% CI) Era of diagnosis (95% CI) Total (95% CI) >1 month–2 years
Male Female White Non ‐ White 1973–1990 1991–2007
Leukemias I Leukemias, myeloproliferative & myelodysplastic diseases: 41.6 (25.9–57.3) 37.7 (22.2–53.2) 39.9 (27.4–52.4) 36.5 (12.4–60.6) 43.3 (15.3–71.3) 38.4 (26.2–50.6) 39.1 (27.9–50.3) 62.8 (60.4–65.2)a
I(a) Lymphoid leukemias 25 (2.9–47.1)
I(b) Acute myeloid leukemias 48.6 (33.1–64.1)
I(e) Unspecified and other specified leukemias 36.8 (13.7–59.9)
CNS tumors III CNS and misc intracranial and intraspinal neoplasms 17 (2.9–31.1) 12.4 (0–25.1) 19.3 (8.1–30.5) 9.1 (0–21.1) 19.1 (5.6–32.6) 15 (5.4–24.6) 58.5 (55.6–61.4)a
III(b) Astrocytomas 22.9 (5.7–40.1)
III(c) Intracranial and intraspinal embryonal tumors 9.4 (0–21.6)
Other solid tumors IV Neuroblastoma and other peripheral nervous cell tumors 79.7 (71.7–87.7) 72.5 (61.9–83.1) 77.8 (70.9–84.7) 70.1 (52.7–87.5) 70.6 (58.8–82.4) 80.1 (72.7–87.5) 76.8 (70.3–83.3) 78.6 (76.4–80.8)a
V Retinoblastoma 83.9 (63.5–100) 100 91.7 (80.5–100) 95.7 (94.1–97.3)b
VI(a) Nephroblastoma and other nonepithelial renal tumors 62.5 (38.8–86.2) 87.9 (85.4–90.4)a
IX Soft tissue and other extraosseous sarcomas 46.7 (25.7–67.7) 59.8 (39.2–80.4) 62.5 (38.8–86.2) 45 (25.6–64.4) 52.4 (37.5–67.3) 71.5 (67–76)a
IX(a) Rhabdomyosarcomas 36.3 (12.8–59.8)
IX(b) Fibrosarcomas, peripheral nerve & other fibrous 76 (57.4–94.6)
IX(d) Other specified soft tissue sarcomas 31.1 (0–64)
X Germ cell & trophoblastic tumors & neoplasms of gonads 61.9 (48–75.8) 71.7 (62.7–80.7) 68.9 (60.5–77.3) 66.9 (49.7–84.1) 51.2 (30.4–72) 71.3 (63.3–79.3) 68.3 (60.7–75.9) 84 (79.9–88.1)a
X(a) Intracranial & intraspinal germ cell tumors 25 (6–44)
X(b) Extracranial & extragonadal germ cell tumors 63.1 (47.6–78.6) 80.7 (72.1–89.3) 75.1 (66.5–83.7) 73.5 (56.3–90.7) 51.2 (30.4–72) 79.2 (71–87.4) 74.5 (66.7–82.3)
Grand Total 59.3 (53.4–65.2) 61.3 (55.6–67) 60.8 (56.3–65.3) 57.2 (47.2–67.2) 57.3 (49.5–65.1) 61.3 (56.4–66.2) 60.3 (56.2–64.4) 72.7 (71.7–73.7)a

RTh, radiation therapy; Surg, surgery.

P ≤ 0.001.

a

No statistics were calculated because the group had fewer than 10 patients.

b

P = 0.043.